Diagnostics | Free Full-Text | A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come
Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers | PLOS ONE
Ovarian Cancer | AACC.org
249 Multimarker Serum Testing Related to Ovarian Cancer
Cancers | Free Full-Text | CA125 and Ovarian Cancer: A Comprehensive Review
Potential Markers for Detection and Monitoring of Ovarian Cancer
Prediction of the treatment response in ovarian cancer: a ctDNA approach | Journal of Ovarian Research | Full Text
The OVA1 Test Improves the Preoperative Assessment of Ovarian Tumors Frederick Ueland, Chris Desimone, Leigh Seamon, Rachel Ware, Scott Goodrich, Iwona. - ppt download
Ova1Plus - Aspira Women's Health
Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers | PLOS ONE
Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125 | Communications Biology
Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer | Scientific Reports
OVA1 Detects More Ovarian Cancers than CA 125 - CancerConnect
Team:Evry/Design - 2015.igem.org
OVA1 (Vermillion)
FEP Medical Policy Manual
Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers | PLOS ONE
A New Test to See If Ovarian Masses Are Cancerous - WSJ
Cancers | Free Full-Text | Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
Ova1Plus - Aspira Women's Health
OVA1 Products - Aspira Women's Health
Prediction of the treatment response in ovarian cancer: a ctDNA approach | Journal of Ovarian Research | Full Text
Specificity at Landmark Threshold Sensitivity Values of Logistic... | Download Table
OVA1 Products - Aspira Women's Health
The OVA1: a breakthrough in evaluating adnexal mass
Q3 Digital Landing Page - Aspira Women's Health
Ovarian Cancer: What is OVA1® Test? | Fox Chase Cancer Center - Philadelphia PA
